Biomodels

Biomodels was founded in 1997 with the idea of creating a more useful interface between leading academic researchers and the pharmaceutical industry. To achieve this goal, Biomodels established an independent company, formed cooperative relationships with renowned academic scientists, and obtained the rights to use proprietary models and technologies for commercial purposes. Biomodels provides its clients with selected predictive models in the fields of cancer, supportive cancer care, radiation therapy, and inflammatory diseases. Additionally, through a series of collaborations with leading academic researchers and institutions, Biomodels offers its clients superior preclinical advice. Thanks to these collaborations, Biomodels’ clients gain access to exceptional research and can be confident that they can rely on the results to evaluate the likelihood of clinical success. Several of the largest and most respected pharmaceutical companies in the world, as well as many small and medium-sized enterprises, frequently engage Biomodels for outsourced preclinical studies.